DK0956010T3 - Farmaceutiske mikrosfærer indeholdende valproinsyre til oral administrering - Google Patents

Farmaceutiske mikrosfærer indeholdende valproinsyre til oral administrering

Info

Publication number
DK0956010T3
DK0956010T3 DK97943943T DK97943943T DK0956010T3 DK 0956010 T3 DK0956010 T3 DK 0956010T3 DK 97943943 T DK97943943 T DK 97943943T DK 97943943 T DK97943943 T DK 97943943T DK 0956010 T3 DK0956010 T3 DK 0956010T3
Authority
DK
Denmark
Prior art keywords
oral administration
valproic acid
microspheres containing
containing valproic
pharmaceutical microspheres
Prior art date
Application number
DK97943943T
Other languages
English (en)
Inventor
Christian Langlois
Jean-Yves Lanne
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0956010T3 publication Critical patent/DK0956010T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97943943T 1996-10-07 1997-10-03 Farmaceutiske mikrosfærer indeholdende valproinsyre til oral administrering DK0956010T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612201A FR2754177B1 (fr) 1996-10-07 1996-10-07 Microspheres pharmaceutiques d'acide valproique pour administration orale
PCT/FR1997/001762 WO1998015268A1 (fr) 1996-10-07 1997-10-03 Microspheres pharmaceutiques d'acide valproique pour administration orale

Publications (1)

Publication Number Publication Date
DK0956010T3 true DK0956010T3 (da) 2002-08-12

Family

ID=9496427

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97943943T DK0956010T3 (da) 1996-10-07 1997-10-03 Farmaceutiske mikrosfærer indeholdende valproinsyre til oral administrering

Country Status (40)

Country Link
US (3) US20020001598A1 (da)
EP (1) EP0956010B1 (da)
JP (1) JP3523270B2 (da)
KR (1) KR100334687B1 (da)
CN (1) CN100367945C (da)
AR (1) AR013613A1 (da)
AT (1) ATE216228T1 (da)
AU (1) AU731235B2 (da)
BR (1) BR9712268A (da)
CA (1) CA2267096C (da)
CO (1) CO4900080A1 (da)
CZ (1) CZ288876B6 (da)
DE (1) DE69712100T2 (da)
DK (1) DK0956010T3 (da)
DZ (1) DZ2316A1 (da)
EE (1) EE03744B1 (da)
EG (1) EG24070A (da)
ES (1) ES2174293T3 (da)
FR (1) FR2754177B1 (da)
HK (1) HK1021939A1 (da)
HR (1) HRP970537B1 (da)
HU (1) HU225103B1 (da)
ID (1) ID24596A (da)
IL (1) IL128745A (da)
IS (1) IS1985B (da)
ME (1) ME00664B (da)
MY (1) MY120521A (da)
NO (1) NO325723B1 (da)
NZ (1) NZ334399A (da)
PL (1) PL190105B1 (da)
PT (1) PT956010E (da)
RS (1) RS49602B (da)
RU (1) RU2177315C2 (da)
SI (1) SI0956010T1 (da)
SK (1) SK282113B6 (da)
TR (1) TR199900789T2 (da)
TW (1) TW508251B (da)
UY (1) UY24738A1 (da)
WO (1) WO1998015268A1 (da)
ZA (1) ZA978954B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775995B2 (en) * 1999-06-07 2004-08-19 Nycomed Gmbh Novel preparation and administration form comprising an acid-labile active compound
CA2508855A1 (en) * 2002-12-16 2004-07-01 Frank Slade Abbott Valproic acid analogues and pharmaceutical compositions thereof
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
MX2007002682A (es) * 2004-09-07 2008-03-05 Orphan Medical Inc Composiciones mejoradas de gamma-hidroxibutirato ghb.
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
CN101543631B (zh) * 2008-03-28 2012-01-11 沈阳兴齐制药有限公司 含蜂蜡的微球基质、含有它的药物组合物及其用途
AU2010248292B2 (en) * 2009-05-12 2014-06-12 Amorepacific Corporation Composition for preventing hair loss or for stimulating hair growth
EA201600387A1 (ru) * 2013-11-13 2016-08-31 Тиллоттс Фарма АГ Дисперсная система доставки лекарственного вещества
CN104013596A (zh) * 2014-05-16 2014-09-03 安士制药（中山）有限公司 一种丙戊酸软胶囊及其制备方法
CN105456217A (zh) * 2014-08-27 2016-04-06 捷思英达医药技术（上海）有限公司 一种双丙戊酸钠缓释剂组合物及其制备方法
JPWO2019039346A1 (ja) 2017-08-24 2020-03-26 三井化学株式会社 電池用非水電解液及びリチウム二次電池
CN111033865A (zh) 2017-08-24 2020-04-17 三井化学株式会社 锂二次电池及非水电解液
FR3087445B1 (fr) * 2018-10-19 2021-12-17 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition lipidique pour l'encapsulation d'une substance active et permettant le controle de la vitesse de liberation de ladite substance active
CN111012753A (zh) * 2020-01-07 2020-04-17 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法
CN112274499A (zh) * 2020-11-16 2021-01-29 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2293974A1 (fr) * 1973-03-02 1976-07-09 Kaltenbach Roger Procede et dispositif pour la granulation reguliere de divers produits
US5212326A (en) * 1979-08-20 1993-05-18 Abbott Laboratories Sodium hydrogen divalproate oligomer
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
US5185159A (en) * 1983-07-20 1993-02-09 Sanofi Pharmaceutical composition based on valproic acid and a process for preparing it
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
TW209174B (da) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
ATE120089T1 (de) * 1991-05-20 1995-04-15 Marion Laboratories Inc Mehrschichtige zubereitung mit kontrollierter freisetzung.
FR2682677A1 (fr) * 1991-10-17 1993-04-23 Sanofi Elf Complexe forme de l'acide propyl-2 pentene-2 ouique (e) et de son sel de sodium, sa preparation et compositions pharmaceutiques le contenant.
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US5690959A (en) * 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці

Also Published As

Publication number Publication date
CZ288876B6 (cs) 2001-09-12
HUP9903855A2 (hu) 2000-05-28
HK1021939A1 (en) 2000-07-21
TW508251B (en) 2002-11-01
JP3523270B2 (ja) 2004-04-26
SK36499A3 (en) 2000-12-11
HRP970537A2 (en) 1998-08-31
US20060263437A1 (en) 2006-11-23
US20030157177A1 (en) 2003-08-21
PT956010E (pt) 2002-08-30
DE69712100D1 (de) 2002-05-23
PL332249A1 (en) 1999-08-30
NO325723B1 (no) 2008-07-07
AU731235B2 (en) 2001-03-29
US20020001598A1 (en) 2002-01-03
FR2754177A1 (fr) 1998-04-10
EP0956010B1 (fr) 2002-04-17
SK282113B6 (sk) 2001-11-06
AU4560297A (en) 1998-05-05
HU225103B1 (en) 2006-06-28
US8535721B2 (en) 2013-09-17
BR9712268A (pt) 1999-08-31
ME00664B (me) 2007-06-04
IL128745A0 (en) 2000-01-31
CA2267096C (fr) 2003-09-16
RU2177315C2 (ru) 2001-12-27
EP0956010A1 (fr) 1999-11-17
SI0956010T1 (en) 2002-10-31
NO991613L (no) 1999-04-06
ID24596A (id) 2000-07-27
DE69712100T2 (de) 2002-11-28
WO1998015268A1 (fr) 1998-04-16
HRP970537B1 (en) 2002-08-31
IL128745A (en) 2004-05-12
TR199900789T2 (xx) 1999-07-21
YU17899A (sh) 2000-03-21
EG24070A (en) 2008-05-11
ZA978954B (en) 1999-04-07
ATE216228T1 (de) 2002-05-15
RS49602B (sr) 2007-06-04
HUP9903855A3 (en) 2000-06-28
JP2000504038A (ja) 2000-04-04
CO4900080A1 (es) 2000-03-27
CN1232391A (zh) 1999-10-20
PL190105B1 (pl) 2005-10-31
DZ2316A1 (fr) 2002-12-28
IS4996A (is) 1999-03-11
CZ121199A3 (cs) 1999-08-11
CA2267096A1 (fr) 1998-04-16
NO991613D0 (no) 1999-04-06
IS1985B (is) 2005-02-15
KR20000048828A (ko) 2000-07-25
KR100334687B1 (ko) 2002-04-27
UY24738A1 (es) 2001-05-31
EE9900140A (et) 1999-12-15
EE03744B1 (et) 2002-06-17
CN100367945C (zh) 2008-02-13
FR2754177B1 (fr) 1999-08-06
MY120521A (en) 2005-11-30
NZ334399A (en) 2000-05-26
AR013613A1 (es) 2001-01-10
ES2174293T3 (es) 2002-11-01

Similar Documents

Publication Publication Date Title
IL116673A (en) Stable oral pharmaceutical composition containing an acid labile benzimidazole
DK0956010T3 (da) Farmaceutiske mikrosfærer indeholdende valproinsyre til oral administrering
DK0510404T3 (da) Gastroresistente farmaceutiske formuleringer til oral administration indeholdende galdesyresalte
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
ATE255117T1 (de) Aminophosphonsäure-derivate als arzneimittel
ITMI941262A0 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
DK0616802T3 (da) Oralt præparat til frigivelse i de nedre fordøjelseskanaler
DE69708130D1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
ITMI950961A0 (it) Composizioni farmaceutiche contenenti gemfibrozil
FI952377A0 (fi) Farmaseuttisia ibuprofeenikoostumuksia
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
ITMI962507A0 (it) Composizioni farmaceutiche orali liquide contenenti acidi colanici